NCT00063479已完成2 期
Bisphosphonate Treatment of Osteogenesis Imperfecta
适应症
相关药物
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 入组人数
- 158
- 试验地点
- 19
- 主要终点
- Change in lumbar spine bone mineral density at month 12 relative to baseline
研究概览
简要总结
The primary purpose of this trial is to evaluate whether the investigational medication is safe, effective and has the ability to increase spine bone density in osteogenesis imperfecta (OI) patients.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 3 Months 至 17 Years（Child）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
结局指标
主要结局
Change in lumbar spine bone mineral density at month 12 relative to baseline
次要结局
- Change in Z score of the lumbar spine at month 12 relative to baseline
研究者
研究点 (19)
Loading locations...
相似试验
已完成
4 期
Bisphosphonate Therapy for Osteogenesis ImperfectaPaget Disease of BoneOsteoporosisOsteogenesis ImperfectaNCT00159419Indiana University School of Medicine18
终止
1 期
Pilot Study of Bisphosphonates for Breast CancerBreast NeoplasmsNCT02781805University of Wisconsin, Madison6
招募中
3 期
Bisphosphonate Use to Mitigate Bone Loss Secondary to Bariatric SurgeryBone LossNCT04922333Wake Forest University Health Sciences200
已完成
不适用
Efficacy and Safety on the Use of Bisphosphonates in PaediatricsBone FragileBisphosphonate-Associated OsteonecrosisChildrenAdverse EventsNCT04012320Centre Hospitalier Universitaire de Nīmes99
已完成
不适用
Examination of utility of bisphosphonate to osteoporosis by ovarian insufficiency after gynecologic cancer treatmentOsteoporosis after gynecologic cancer treatmentJPRN-UMIN000005665Gifu University50